论文部分内容阅读
目的:观察强心饮治疗慢性充血性心力衰竭(CHF)的临床疗效。方法:将70例气虚(阳虚)血瘀证、水饮、痰浊内停证的CHF患者随机分为治疗组35例和对照组35例。对照组予常规西医治疗,治疗组在对照组治疗基础上加用强心饮,均连续治疗21天,比较2组临床症状,中医证候及心功能。结果:治疗组显效51%,总有效率为97%;对照组显效率为34%,总有效率为83%。两组显效率、总有效率差异性均有显著性意义(P<0.05)。治疗后两组中医证候积分较治疗前显著改善(P<0.05)且治疗组改善更为显著,与对照组比较,差异性有显著性意义(P<0.05)。结论:在常规西医治疗基础上服用强心饮,可进一步改善患者的临床症状,心功能及生活质量。
Objective: To observe the clinical effect of Qiangxin Decoction on chronic congestive heart failure (CHF). Methods: A total of 70 CHF patients with deficiency of qi (yang) blood stasis syndrome, water drink and phlegm turbidity were randomly divided into treatment group (35 cases) and control group (35 cases). The control group was treated with conventional western medicine. The treatment group was treated with Qiangxin Decoction on the basis of the control group for 21 consecutive days. The clinical symptoms, TCM syndromes and cardiac function were compared between the two groups. Results: The treatment group markedly effective 51%, the total effective rate was 97%; the control group markedly effective rate was 34%, the total effective rate was 83%. The two groups were markedly effective, total effective rate differences were significant (P <0.05). After treatment, the scores of TCM syndromes in both groups were significantly improved (P <0.05), and the improvement in the treatment group was more significant. Compared with the control group, the difference was significant (P <0.05). Conclusion: Taking Qinshenyin on the basis of routine Western medical treatment can further improve the clinical symptoms, cardiac function and quality of life of patients.